IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,626,397 | +30.9% | 1,173,686 | +55.6% | 0.44% | +42.0% |
| Q2 2023 | $14,234,603 | +17303.4% | 754,351 | +3441.6% | 0.31% | +15500.0% |
| Q1 2023 | $81,792 | -96.7% | 21,300 | -95.7% | 0.00% | -96.5% |
| Q4 2022 | $2,473,552 | -18.3% | 498,700 | -6.6% | 0.06% | -32.1% |
| Q3 2021 | $3,027,000 | +2487.2% | 534,000 | +2001.5% | 0.08% | +950.0% |
| Q2 2020 | $117,000 | +41.0% | 25,410 | +5.0% | 0.01% | +14.3% |
| Q1 2020 | $83,000 | +6.4% | 24,200 | -33.0% | 0.01% | 0.0% |
| Q2 2019 | $78,000 | -2.5% | 36,095 | +22.9% | 0.01% | -12.5% |
| Q1 2019 | $80,000 | – | 29,370 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |